339 related articles for article (PubMed ID: 17641155)
21. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor.
Deterding RR; Havill AM; Yano T; Middleton SC; Jacoby CR; Shannon JM; Simonet WS; Mason RJ
Proc Assoc Am Physicians; 1997 May; 109(3):254-68. PubMed ID: 9154642
[TBL] [Abstract][Full Text] [Related]
22. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
23. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
Yao HW; Zhu JP; Zhao MH; Lu Y
Respiration; 2006; 73(2):236-42. PubMed ID: 16330873
[TBL] [Abstract][Full Text] [Related]
24. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis.
Vyalov SL; Gabbiani G; Kapanci Y
Am J Pathol; 1993 Dec; 143(6):1754-65. PubMed ID: 7504890
[TBL] [Abstract][Full Text] [Related]
25. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats.
Panos RJ; Bak PM; Simonet WS; Rubin JS; Smith LJ
J Clin Invest; 1995 Oct; 96(4):2026-33. PubMed ID: 7560096
[TBL] [Abstract][Full Text] [Related]
26. Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits.
Günther A; Lübke N; Ermert M; Schermuly RT; Weissmann N; Breithecker A; Markart P; Ruppert C; Quanz K; Ermert L; Grimminger F; Seeger W
Am J Respir Crit Care Med; 2003 Dec; 168(11):1358-65. PubMed ID: 14644925
[TBL] [Abstract][Full Text] [Related]
27. Bronchoalveolar lavage lipids during development of bleomycin-induced fibrosis in rats. Relationship to altered epithelial cell morphology.
Low RB; Adler KB; Woodcock-Mitchell J; Giancola MS; Vacek PM
Am Rev Respir Dis; 1988 Sep; 138(3):709-13. PubMed ID: 2462382
[TBL] [Abstract][Full Text] [Related]
28. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
29. [Relationship between bleomycin-induced pulmonary fibrosis and vascular endothelial cell injury].
Wei JG; Cui GB; Wang W; Wei LX; Liang GM; Song LJ; Xu JK
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):354-7. PubMed ID: 15555311
[TBL] [Abstract][Full Text] [Related]
30. Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis.
Song JS; Kang CM; Rhee CK; Yoon HK; Kim YK; Moon HS; Park SH
Exp Lung Res; 2009 Dec; 35(10):817-29. PubMed ID: 19995276
[TBL] [Abstract][Full Text] [Related]
31. [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
Fang X; Zhu Y; Hu X; Liu Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):268-72. PubMed ID: 12133317
[TBL] [Abstract][Full Text] [Related]
32. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function.
Murphy S; Lim R; Dickinson H; Acharya R; Rosli S; Jenkin G; Wallace E
Cell Transplant; 2011; 20(6):909-23. PubMed ID: 21092408
[TBL] [Abstract][Full Text] [Related]
33. Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA.
Li X; Zhuang J; Rayford H; Zhang H; Shu R; Uhal BD
Curr Pharm Des; 2007; 13(12):1257-68. PubMed ID: 17504234
[TBL] [Abstract][Full Text] [Related]
34. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats.
Long X; Xiong SD; Xiong WN; Xu YJ
Chin Med J (Engl); 2007 Aug; 120(16):1432-7. PubMed ID: 17825173
[TBL] [Abstract][Full Text] [Related]
35. Increased endothelin-1 and its localization during the development of bleomycin-induced pulmonary fibrosis in rats.
Mutsaers SE; Foster ML; Chambers RC; Laurent GJ; McAnulty RJ
Am J Respir Cell Mol Biol; 1998 May; 18(5):611-9. PubMed ID: 9569231
[TBL] [Abstract][Full Text] [Related]
36. Bleomycin-induced pulmonary fibrosis in the rat. Prevention with an inhibitor of collagen synthesis.
Kelley J; Newman RA; Evans JN
J Lab Clin Med; 1980 Dec; 96(6):954-64. PubMed ID: 6159435
[TBL] [Abstract][Full Text] [Related]
37. Increased type I procollagen mRNA transcripts in the lungs of mice during the development of bleomycin-induced fibrosis.
Shahzeidi S; Jeffery PK; Laurent GJ; McAnulty RJ
Eur Respir J; 1994 Nov; 7(11):1938-43. PubMed ID: 7533103
[TBL] [Abstract][Full Text] [Related]
38. Alveolar accumulation of hyaluronan and alveolar cellular response in bleomycin-induced alveolitis.
Nettelbladt O; Scheynius A; Bergh J; Tengblad A; Hällgren R
Eur Respir J; 1991 Apr; 4(4):407-14. PubMed ID: 1713172
[TBL] [Abstract][Full Text] [Related]
39. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair.
Moodley Y; Ilancheran S; Samuel C; Vaghjiani V; Atienza D; Williams ED; Jenkin G; Wallace E; Trounson A; Manuelpillai U
Am J Respir Crit Care Med; 2010 Sep; 182(5):643-51. PubMed ID: 20522792
[TBL] [Abstract][Full Text] [Related]
40. [Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin].
Li W; Hu Y; Yuan W; Li L; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):221-5. PubMed ID: 22381763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
